Supernus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
SUPN Key Statistics
Stock Snapshot
With a market cap of 2.99B, Supernus Pharmaceuticals(SUPN) trades at $52.51. The stock has a price-to-earnings ratio of -100.66.
On 2026-05-10, Supernus Pharmaceuticals(SUPN) stock traded between a low of $50.36 and a high of $52.79. Shares are currently priced at $52.51, which is +4.3% above the low and -0.5% below the high.
The Supernus Pharmaceuticals(SUPN)'s current trading volume is 854.62K, compared to an average daily volume of 974.27K.
During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $30.83 at its lowest and $59.68 at its peak.
During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $30.83 at its lowest and $59.68 at its peak.
SUPN News
Supernus Pharmaceuticals (SUPN) is back in focus after reporting first quarter 2026 results that topped Wall Street earnings and revenue expectations, with Qelb...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.